MediWound Q4 Earnings Call Highlights [Yahoo! Finance]
MediWound Ltd. - Ordinary Shares (MDWD)
Last mediwound ltd. - ordinary shares earnings: 2/25 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.mediwound.com/press-releases
Company Research
Source: Yahoo! Finance
EscharEx chronic wound program and the completion of an expanded manufacturing facility for NexoBrid, while also acknowledging revenue headwinds tied to U.S. government disruptions. EscharEx Phase III program advances, expansion planned into additional indications Chief Executive Officer Ofer Gonen said MediWound ended 2025 with “two significant growth drivers firmly in place,” led by the ongoing global Phase III VALUE trial for EscharEx in venous leg ulcers (VLUs). Management said enrollment is ongoing, with the majority of sites active and enrolling, and the study is targeting 216 patients across approximately 40 sites in the U.S. and Europe. ? IonQ in Rebound Mode: Buy the Thesis, Respect the Risk The company reiterated expectations for both the pre-specified interim assessment and completion of enrollment by the end of 2026. On the call, management said the interim sample size assessment is scheduled after about 65% of patients complete treatment. Gonen explained that the
Show less
Read more
Impact Snapshot
Event Time:
MDWD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDWD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDWD alerts
High impacting MediWound Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
MDWD
News
- MediWound outlines $24M–$26M 2026 revenue target while expanding EscharEx clinical programs [Seeking Alpha]Seeking Alpha
- MediWound Ltd. (MDWD) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- MediWound Files Annual Report on Form 20-F [Yahoo! Finance]Yahoo! Finance
- MediWound Files Annual Report on Form 20-FGlobeNewswire
- MediWound Ltd. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
MDWD
Earnings
- 3/5/26 - Beat
MDWD
Sec Filings
- 3/5/26 - Form S-8
- 3/5/26 - Form 20-F
- 3/5/26 - Form 6-K
- MDWD's page on the SEC website